We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mitragynine ELISA Detects Designer Drug

By LabMedica International staff writers
Posted on 17 Apr 2013
A designer drug originates from Mitragyna speciosa, an uncontrolled plant found in South East Asia. More...


Called Kratom, the drug has become more popular because it is easily available on the internet and in head shops [shops specializing in paraphernalia used with or related to illegal drugs]. It is marketed as a means to combat fatigue, pain, and depression. A new immunoassay for Kratom was developed by Randox Toxicology (Crumlin, United Kingdom) and provides a rapid solution for the detection of Mitragynine and its metabolites.

From exotic plants to synthetic blends, designer drugs are problematic for forensic toxicologists as waves of new compounds with differing chemical properties quickly flood the market. Immunoassays provide a straightforward method for laboratory drug screening, allowing a large number of specimens to be screened relatively quickly. A novel ELISA developed by Randox Toxicology can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing valuable information for further analysis.

The Randox Toxicology enzyme-linked immunosorbent assay (ELISA) can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine, and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing important information for further analysis.

As with other designer drugs such as “Spice” and “Bath Salts,” Kratom is marketed as a “legal high,” which can mislead users to believe that the drug is safe to use. Several cases of psychosis resulting from the use of Kratom have been reported, with individuals addicted to the drug exhibiting psychotic symptoms such as hallucinations, delusion, and confusion. Mitragynine and several related alkaloids naturally occur in the Mitragyna speciosa plant, creating psychoactive properties.

Randox Toxicology, through its research and development capabilities, is able to quickly develop reliable assays for designer drugs. The company has developed a range of rapid immunoassays on ELISA and Biochip arrays, including Synthetic Cannabinoids and Synthetic Cathinones, commonly referred to as “Bath Salts.”

Related Links:
Randox Toxicology


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.